LCI VS MEDS Stock Comparison

PerformanceForecastTechnicalsEarningsProfitVolatility
PerformanceForecastTechnicalsEarningsProfitVolatility

Performance

LCI
10/100

LCI returned -74.42% in the last 12 months. Based on the other stocks in its sector with an average return of -23.90%, its performance is below average giving it a grade of 10 of 100.

MEDS
10/100

MEDS returned -41.09% in the last 12 months. Based on SPY's performance of -13.95%, its performance is below average giving it a score of 10 of 100.

Forecast

LCI
64/100

7 analysts offer 12-month price forecasts for LCI. Together, they have an average target of 0, the most optimistic forecast put LCI at 0 within 12-months and the most pessimistic has LCI at 0.

MEDS

"Forecast" not found for MEDS

Technicals

LCI
21/100

LCI receives a 21 of 100 based on 14 indicators. 3 are bullish, 11 are bearish.

MEDS
36/100

MEDS receives a 35 of 100 based on 14 indicators. 4 are bullish, 8 are bearish.

Earnings

LCI
10/100

LCI has missed earnings 9 times in the last 20 quarters.

MEDS
10/100

MEDS has missed earnings 9 times in the last 20 quarters.

Profit

LCI
10/100

Out of the last 4 quarters, LCI has had 0 profitable quarters and has increased their profits year over year on 0 of them.

MEDS
22/100

Out of the last 20 quarters, MEDS has had 6 profitable quarters and has increased their profits year over year on 2 of them.

Volatility

LCI
48/100

LCI has had a lower than average amount of volatility over the last 12 months giving it a grade of 47 of 100.

MEDS
52/100

MEDS has had a higher than average amount of volatility over the last 12 months giving it a score of 52 of 100.

All score calculations are broken down here to help you make more informed investing decisions

Lannett Company, Inc. Summary

New York Stock Exchange / LCI
Healthcare
Drug Manufacturers—Specialty & Generic
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.

TRxADE HEALTH, Inc. Common Stock Summary

Nasdaq / MEDS
Healthcare
Medical - Pharmaceuticals
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.